| Oct 22 |
iRhythm's Stock Skyrockets 17% After Game-Changing FDA Approval -- Is This Just the Beginning?
|
| Oct 22 |
iRhythm Technologies Stock Rises Post FDA Clearance for Zio AT
|
| Oct 22 |
iRhythm shares soar after FDA clears Zio AT device updates
|
| Oct 22 |
iRhythm secures 510(k) clearance for Zio device updates after FDA warning
|
| Oct 22 |
iRhythm gains after FDA nod for Zio AT updates
|
| Oct 21 |
iRhythm Technologies Receives FDA 510(k) Clearance for Design Updates Previously Made to Its Zio® AT Device
|
| Oct 16 |
iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024
|
| Oct 16 |
iRhythm Technologies (IRTC) Slipped on Regulatory Issues
|
| Oct 11 |
Irhythm Technologies Outlines Growth and Market Leadership Strategy
|
| Sep 13 |
iRhythm's Zio ECG System Gets Approval in Japan, Stock Falls
|
